Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plans

v3.21.1
Stock Incentive Plans
 3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock Incentive Plans Stock Incentive Plans
The Company recorded shared-based compensation expense as follows for the three months ended March 31, 2021 and 2020 (in thousands):
Three Months Ended
March 31,
2021		 March 31,
2020
Salaries, wages and employee benefits - continuing operations $ 2,269  $ 2,817 
Salaries, wages and employee benefits - discontinued operation 16 188
Total share-based compensation expense $ 2,285  $ 3,005 

Stock Incentive Plan

In May 2016, the Company adopted the 2016 Omnibus Incentive Compensation Plan (the “Omnibus Plan”) for the issuance of up to 2,000 common shares. As of March 31, 2021, approximately 793 shares remain available for grant under the Omnibus Plan.

Stock Options
     
Share-based compensation expense associated with stock options is amortized ratably over the requisite service period. The Company estimates the fair value of the grants using the Black-Scholes option-pricing model. Stock option transactions during the three months ended March 31, 2021 on a continuing operations basis were as follows:

Stock Options Weighted-Average Exercise Price
Outstanding as of December 31, 2020 359  $ 55.79 
Granted 39  75.05 
Exercised (26) 54.26 
Forfeited —  — 
Outstanding as of March 31, 2021 372  $ 58.06 

As of March 31, 2021, the total share-based compensation expense related to unvested stock options net yet recognized was approximately $1,250, and the weighted average period over which it is expected to be recognized is approximately two years.

Stock option transactions during the three months ended March 31, 2021 on a discontinued operation basis were as follows:
Stock Options Weighted-Average Exercise Price
Outstanding at December 31, 2020 14  $ 52.15 
Granted —  — 
Exercised (14) 52.15 
Forfeited —  — 
Outstanding at March 31, 2021 —  $ — 
Restricted Shares

Restricted shares are restricted from sale or transfer until vesting, and restrictions lapse in three equal installments beginning one year after the date of grant. Share-based compensation expense associated with these awards is amortized ratably over the requisite service period. Restricted share transactions during the three months ended March 31, 2021 on a continuing operations basis were as follows:
Restricted Shares Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2020 213  $ 62.78 
Granted 108  75.14 
Vested (96) 61.38 
Forfeited (11) 69.13 
Outstanding as of March 31, 2021 214  $ 69.31 

As of March 31, 2021, the total share-based compensation expense related to the restricted shares net yet recognized was approximately $13,179, and the weighted-average period over which it is expected to be recognized is approximately two years.

Restricted share transactions during the three months ended March 31, 2021 on a discontinued operation basis were as follows:
Restricted Shares Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2020 8  $ 60.83 
Granted —  — 
Vested (4) 61.78 
Forfeited (4) 61.37 
Outstanding as of March 31, 2021 —  $ — 

Performance Awards

Performance awards are based on achieving certain financial targets, such as targets for earnings before interest, taxes, depreciation and amortization, and the Company’s total shareholder return as compared to the total shareholder return of a selected peer group, as determined by the Company’s Board of Directors. Performance targets are set at the beginning of each three-year measurement period. Share-based compensation expense associated with these awards is amortized ratably over the vesting period. Depending on the financial target, the compensation expense is based on the projected assessment of the level of performance that will be achieved.

Performance award transactions during the three months ended March 31, 2021 on a continuing operations basis were as follows assuming target levels of performance:
Performance Awards Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2020 65  $ 67.62 
Granted 36  87.33 
Earned (11) 92.89 
Forfeited (11) 70.22 
Outstanding as of March 31, 2021 79  $ 75.61 

As of March 31, 2021, the total share-based compensation expense related to unearned performance awards not yet recognized, assuming the Company's current projected assessment of the level of performance that will be achieved, was approximately $3,652, and the weighted-average period over which it is expected to be recognized is approximately three years.


Employee Stock Purchase Plan

Under the 2005 Employee Stock Purchase Plan (the “ESPP”), the Company is authorized to issue up to a remaining 335 shares of common stock to employees. These shares may be issued at a price equal to 90% of the lesser of the market value on the first day or the last day of each six-month purchase period. Common stock purchases are paid for through periodic payroll deductions and/or up to two large lump sum contributions. No shares were issued during the three months ended March 31, 2021.
Director Restricted Shares

Under the Amended and Restated Non-Employee Director Stock Plan (the “Amended Plan”), approved in May 2007 and further amended in February 2013 and January 2016, up to 360 common shares may be issued. As of March 31, 2021, approximately 90 shares remain available for grant under the Amended Plan.

Director restricted share transactions during the three months ended March 31, 2021 were as follows:
Director Restricted Shares Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2020 24  $ 43 
Granted 2  93 
Vested —  — 
Forfeited —  — 
Outstanding as of March 31, 2021 26  $ 47 
For the three-months ended March 31, 2021 and 2020, the Company recorded $328 and $261, respectively, of share-based compensation expense associated with these grants. As of March 31, 2021, the total share-based compensation expense related to the restricted shares net yet recognized was approximately $256.